Heck Capital Advisors’s Cardinal Health CAH Stock Holding History

Heck Capital Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5	Closed	-$591	–	317
2024 Q4	$591	Buy	+5	New	+$584	﹤0.01%	745

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Heck Capital Advisors's CAH Position: Q1 2025 in Review

Heck Capital Advisors sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 5 shares — an estimated $591 sold.

Heck Capital Advisors first reported a position in CAH in Q4 2024 and held it in 1 quarter. The position peaked at $591 in Q4 2024. 1,151 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

Heck Capital Advisors reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 5 Cardinal Health shares in Q1 2025, an estimated $591.
Heck Capital Advisors first reported a position in Cardinal Health in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's Cardinal Health position peaked at $591 in Q4 2024.
1,151 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.